L T Møllehave1, T Skaaby1, K S Simonsen1, B H Thuesen1, E L Mortensen2,3, C H Sandholt4, O Pedersen4, N Grarup4, T Hansen4, A Linneberg1,3,5. 1. Research Centre for Prevention and Health, The Capital Region of Denmark, Copenhagen, Denmark. 2. Center for Healthy Aging, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 3. Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 4. The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 5. Department of Clinical Experimental Research, Rigshospitalet, Copenhagen, Denmark.
Abstract
BACKGROUND/ OBJECTIVES: Observational studies have suggested low serum levels of vitamin B12 or folate to be risk factors of depression and anxiety. However, these results may be biased by confounding and reverse causation. Mendelian randomization studies are not subject to these limitations. The aim was to examine the association of genetic scores of vitamin B12 and folate-associated alleles with depression and anxiety. SUBJECTS/ METHODS: The study included 4126 participants from two Danish population-based studies. Serum vitamin B12 and folate were measured. Weighed allele scores were calculated as the sum of weights (genetic effect sizes) for 12 and two variants increasing circulating levels of vitamin B12 and folate, respectively. Symptoms of depression and anxiety were assessed by the Symptom Check List (SCL)-90-R, and self-reported doctor-diagnosed depression and anxiety. RESULTS: An increased weighed allele score for serum vitamin B12 was associated with decreased odds of a SCL-90-R score above the 90th percentile (OR 0.540 (95%CI 0.302-0.967)) in Health2006 but not in Inter99, in the pooled analysis (OR 0.817 (95%CI 0.331-2.018)) or with other outcomes. The weighed allele score for serum folate was not associated with any of the measured outcome variables: SCL-90-R scores of depression (pooled OR 0.603 (95%CI 0.101-3.602)), anxiety (pooled OR 0.619 (95%CI 0.110-3.495)), combined score or history of doctor-diagnosed depression or anxiety. CONCLUSION: Our results do not provide evidence for a causal effect of circulating folate or vitamin B12 on the risk of depression or anxiety. However, we cannot rule out small to moderate effects, and thus large scale studies are needed.
BACKGROUND/ OBJECTIVES: Observational studies have suggested low serum levels of vitamin B12 or folate to be risk factors of depression and anxiety. However, these results may be biased by confounding and reverse causation. Mendelian randomization studies are not subject to these limitations. The aim was to examine the association of genetic scores of vitamin B12 and folate-associated alleles with depression and anxiety. SUBJECTS/ METHODS: The study included 4126 participants from two Danish population-based studies. Serum vitamin B12 and folate were measured. Weighed allele scores were calculated as the sum of weights (genetic effect sizes) for 12 and two variants increasing circulating levels of vitamin B12 and folate, respectively. Symptoms of depression and anxiety were assessed by the Symptom Check List (SCL)-90-R, and self-reported doctor-diagnosed depression and anxiety. RESULTS: An increased weighed allele score for serum vitamin B12 was associated with decreased odds of a SCL-90-R score above the 90th percentile (OR 0.540 (95%CI 0.302-0.967)) in Health2006 but not in Inter99, in the pooled analysis (OR 0.817 (95%CI 0.331-2.018)) or with other outcomes. The weighed allele score for serum folate was not associated with any of the measured outcome variables: SCL-90-R scores of depression (pooled OR 0.603 (95%CI 0.101-3.602)), anxiety (pooled OR 0.619 (95%CI 0.110-3.495)), combined score or history of doctor-diagnosed depression or anxiety. CONCLUSION: Our results do not provide evidence for a causal effect of circulating folate or vitamin B12 on the risk of depression or anxiety. However, we cannot rule out small to moderate effects, and thus large scale studies are needed.
Authors: L L N Husemoen; T Skaaby; B H Thuesen; N Grarup; C H Sandholt; T Hansen; O Pedersen; A Linneberg Journal: Eur J Clin Nutr Date: 2016-02-24 Impact factor: 4.016
Authors: Elke Biemans; Huberta E Hart; Guy E H M Rutten; Viviana G Cuellar Renteria; Antoinette M J Kooijman-Buiting; Joline W J Beulens Journal: Acta Diabetol Date: 2014-10-15 Impact factor: 4.280
Authors: Jussi Seppälä; Hannu Koponen; Hannu Kautiainen; Johan G Eriksson; Olli Kampman; Jaana Leiviskä; Satu Männistö; Pekka Mäntyselkä; Heikki Oksa; Yrjö Ovaskainen; Merja Viikki; Mauno Vanhala; Jussi Seppälä Journal: BMC Psychiatry Date: 2013-05-24 Impact factor: 3.630
Authors: Rebecca Carnegie; Jie Zheng; Hannah M Sallis; Hannah J Jones; Kaitlin H Wade; Jonathan Evans; Stan Zammit; Marcus R Munafò; Richard M Martin Journal: Lancet Psychiatry Date: 2019-11-20 Impact factor: 27.083